Magnetic Resonance Imaging to Identify Characteristics of Plaque Build-Up in People With Peripheral Arterial Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Peripheral arterial disease (PAD) is a disease in which fatty build-up, or "plaque," accumulates in the peripheral arteries. People with PAD often experience leg pain while walking due to reduced blood flow to the legs. This study will use magnetic resonance imaging (MRI) techniques to examine how specific features of plaque build-up in the leg arteries affect walking ability, leg strength, and balance in people with PAD.
| Condition |
|---|
|
Peripheral Vascular Diseases |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Magnetic Resonance in Peripheral Arterial Disease |
- Functional Performance: 6-minute walk performance [ Time Frame: Baseline, 12 months, 24 months ] [ Designated as safety issue: No ]
- MRI: Mean Plaque Volume [ Time Frame: Baseline, 24 months ] [ Designated as safety issue: No ]
- Four meter walking velocity (usual pace), four meter walking velocity (fastest pace), SPPB [ Time Frame: Baseline, 12 months, 24 months ] [ Designated as safety issue: No ]
- MRI: maximum plaque volume, external remodeling, mean percent lumen reduction, maximum percent lumen reduction [ Time Frame: Baseline, 24 months ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Plasma, serum, and whole blood samples are stored for future analysis
| Enrollment: | 519 |
| Study Start Date: | October 2007 |
| Study Completion Date: | January 2012 |
| Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
Plaque build-up caused by atherosclerosis increases the risk of blood clots, heart attack, and stroke. Blockages of plaque can occur in different areas of the body. PAD, a circulatory disorder in which blockages occur in the peripheral arteries, is one manifestation of atherosclerosis. Individuals with PAD experience reduced blood flow to the legs, which may cause leg pain while walking. This study will use MRI techniques to examine how characteristics of plaque build-up in the leg arteries change over time and how this change affects function, walking ability, leg strength, and balance in people with PAD. Results from this study may be used to shape future research studies that will attempt to identify more effective treatments for people with PAD.
This study will enroll people with PAD, as well as a smaller control group of people who do not have PAD. At an initial study visit, study researchers will interview participants to collect information about their medical history, daily activity level, walking ability, and mental functioning. Blood collection and a leg MRI will occur. Also, blood flow to the legs will be measured by comparing blood pressure measurements in the arms and legs. Leg function will be measured through a series of timed walks, leg strength exercises, and muscle power exercises. Questionnaires to assess participants' medical history will be completed by each participant's primary care doctor, and study researchers will review participants' medical records. Participants with knee pain will have a knee x-ray, and participants may wear a small device called an accelerometer for 1 week to monitor physical activity levels. During the second and third study visits, occurring at one and two year follow-up, blood flow, leg function, and leg strength will be measured. If participants cannot attend either study visit, researchers may visit participants at their home or conduct an interview over the phone. Study researchers may contact participants by phone once or twice a year for follow-up.
Eligibility| Ages Eligible for Study: | 21 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Ankle Brachial Index less than 1 in participants
Inclusion Criteria:
- For participants with PAD: lowest leg ankle-brachial index (ABI) less than or equal to 0.999
- For participants in the control group: lowest ABI between 1.00 to 1.30
Exclusion Criteria:
- Foot amputation, leg amputation, or gangrene
- Recent liver transplantation
- Requires oxygen on ambulation
- End stage renal disease
- Confined to a wheelchair
- Lives in a nursing home
- Low life expectancy
- Mini-Mental Status Exam (MMSE) score of less than 23 out of 30
- Communication difficulty due to language barriers
- Inability to tolerate MRI testing for any reason
- Six-minute walk performance limited primarily by pulmonary disease, legal blindness, or severe lower extremity arthritis
Contacts and Locations| United States, Illinois | |
| Northwestern University | |
| Chicago, Illinois, United States, 60611 | |
| Principal Investigator: | Mary M. McDermott, MD | Northwestern University |
More Information
No publications provided by Northwestern University
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Mary McDermott, Principal Investigator, Northwestern University |
| ClinicalTrials.gov Identifier: | NCT00520312 History of Changes |
| Other Study ID Numbers: | 1396, R01HL083064-01A2, R01 HL083064-01A2 |
| Study First Received: | August 23, 2007 |
| Last Updated: | July 27, 2012 |
| Health Authority: | United States: Federal Government |
Keywords provided by Northwestern University:
|
Peripheral Arterial Disease PAD Functional Impairment Magnetic Resonance Imaging |
Additional relevant MeSH terms:
|
Vascular Diseases Peripheral Vascular Diseases Peripheral Arterial Disease Cardiovascular Diseases |
Atherosclerosis Arteriosclerosis Arterial Occlusive Diseases |
ClinicalTrials.gov processed this record on June 17, 2013